Skip to main content
OpenTrials
Completed

NCT Number: NCT06217718

The Effect of Telenursing Interventions in Empowering Patients With COPD

The aim of this study is to evaluate the effect of telenursing interventions based on the empowerment model in empowering patients with COPD.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

COPD Behavior Chronic Disease Disease Attributes Empowerment Empowerment, Patient Health Behavior Lung Diseases Lung Diseases, Obstructive Pathologic Processes Pathological Conditions, Signs and Symptoms Patient Acceptance of Health Care Patient Participation Pulmonary Disease, Chronic Obstructive Respiratory Tract Diseases Self Efficacy Social Behavior Treatment Adherence and Compliance

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital

Istanbul, Maltepe, 34844, Turkey (Türkiye)

About this study

Patient empowerment is gaining importance and popularity day by day as it can be sustained through telehealth applications. The importance of using communication technologies in providing health care services has become more evident during the COVID-19 pandemic. When integrated into healthcare, technology-centric services provide continuous and easily accessible health data for patients and help facilitate self-monitoring. With tele-nursing, COPD patients can be strengthened in health literacy by teaching them how to access accurate and reliable resources. Through tele-nursing, online support groups and forums can be created among COPD patients so that patients can share their experiences with each other. In this way, social support is provided to patients who have to remain in social isolation due to their illness.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Having a confirmed COPD diagnosis for at least one year
  • being literate,
  • Having the cognitive and mental competence to answer questions,
  • Being able to use a mobile phone,
  • Disease symptoms are at a level that does not interfere with communication,
  • Being in COPD Stage 2 and Stage 3 according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD: Global Initiative for Chronic Obstructive Lung Disease) criteria (30% ≤ FEV1 <80% (of expected)),

Exclusion criteria

  • The disease is in the acute exacerbation period,
  • Dyspnea is at a level that prevents cooperation,
  • Having sensory loss regarding vision, hearing and speech,
  • Refusal to sign informed consent forms
  • It is the refusal of the research to complete the data collection tools.

Treatment and study plan

Telenursing Interventions

Other

Patient follow-up with phone calls and text messages

Primary outcomes

  1. COPD Empowerment Scale

    Time frame: Pre-test, Post-test (3rd month), Follow-up Test (6th month)

    A 31-item scale that evaluates the impact of interventions on individuals with COPD.

Secondary outcomes

  1. Lung Function Test

    Time frame: Pre-test, Post-test (3rd month), Follow-up Test (6th month)

    A spirometri test that evaluates lung capacity. FEV1 values will increase after the intervention.

  2. COPD Assesment Test

    Time frame: Pre-test, Post-test (3rd month), Follow-up Test (6th month)

    It is an eight-item test that measures the effects of COPD and deterioration in health status. CAT assessment test score; 0-10 is low 11-20 is considered medium effective, 21-30 is considered highly effective, and 31-40 is considered very high effective.

  3. Number of hospital admissions due to COPD exacerbation

    Time frame: Pre-test, Post-test (3rd month), Follow-up Test (6th month)

    The number of hospital admissions due to COPD exacerbation in the experimental group will decrease.

  4. Number of hospitalizations due to COPD exacerbation

    Time frame: Pre-test, Post-test (3rd month), Follow-up Test (6th month)

    The number of hospitalizations due to COPD exacerbation in the experimental group will decrease.

  5. Modified Barthel Index

    Time frame: Pre-test, Post-test (3rd month), Follow-up Test (6th month)

    A scale that evaluates physical competence and independence in daily living activities. It evaluates 0-15 points with 10 items. On this scale, where the possible score varies between 0 and 100, the higher the score, the more independent the patient is from other people.

  6. Modified Medical Research Council

    Time frame: Pre-test, Post-test (3rd month), Follow-up Test (6th month)

    A brief 5-item scale describing dyspnea. Scores between 0 and 1 are considered mild, and scores of 2 and above are considered moderate to severe dyspnea.

  7. Inhaler Device Use Skill Scale

    Time frame: Pre-test, Post-test (3rd month), Follow-up Test (6th month)

    An observational test that measures inhaler device usage skill, with 10 usage steps explained. 1 point for correct use of each item; Incomplete or incorrect use is given 0 points.

Sponsors and collaborators

Lead sponsor

Zahide Aksoy

Other

Collaborators

  • The Scientific and Technological Research Council of Turkey

Registry information

Official study title

The Effect of Empowerment Model-Based Telenursing Interventions in Empowering Patients With COPD

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Jan 22, 2024
Registry last updated
Mar 11, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.